ONYX 18

Device Medtronic, Inc.
Total Payments
$6.8M
Transactions
1,878
Doctors
487
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $1.2M 464 152
2023 $2.8M 550 151
2022 $2.7M 864 264

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $6.4M 813 94.8%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $179,728 70 2.7%
Consulting Fee $128,826 38 1.9%
Food and Beverage $28,607 838 0.4%
Travel and Lodging $16,967 118 0.3%
Education $82.42 1 0.0%

Payments by Type

Research
$6.4M
813 transactions
General
$354,211
1,065 transactions

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
EMBOLISE Medtronic, Inc. $6.3M 19
Onyx ONE Clear Medtronic, Inc. $148,422 0

Top Doctors Receiving Payments for ONYX 18 — Page 20

Doctor Specialty Location Total Records
, ARNP Nurse Practitioner Hudson, FL $6.48 1
, M.D Student in an Organized Health Care Education/Training Program Detroit, MI $5.61 1
, MD Vascular & Interventional Radiology Iowa City, IA $5.50 1
, MD Vascular Neurology Indianapolis, IN $5.27 1
, M.D Neuroradiology Little Rock, AR $4.61 1
, MD Student in an Organized Health Care Education/Training Program Atlanta, GA $4.41 1
, MBBS, MD Internal Medicine East Lansing, MI $3.71 1
, MD Interventional Cardiology Wausau, WI $3.48 1
, M.D Neurology Atlanta, GA $3.41 1
, M.D Neurology Wyoming, MI $1.96 1
Sonia White Family Arlington, VA $1.49 1
, CNP Acute Care Cleveland, OH $1.23 1
Samantha Gold Critical Care Medicine Cleveland, OH $1.23 1

About ONYX 18

ONYX 18 is a device associated with $6.8M in payments to 487 healthcare providers, recorded across 1,878 transactions in the CMS Open Payments database. The primary manufacturer is Medtronic, Inc..

Payment data is available from 2022 to 2024. In 2024, $1.2M was paid across 464 transactions to 152 doctors.

The most common payment nature for ONYX 18 is "Unspecified" ($6.4M, 94.8% of total).

ONYX 18 is associated with 2 research studies, including "EMBOLISE" ($6.3M).